Researchers from the VIB-KU Leuven Center for Cancer Biology, in collaboration with other scientists, have discovered a way ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

The scoring method, called the Tumor Immune Microenvironment Spatial System, or TIMES, is the first tool in the world to ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...

The following is a summary of "Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines," ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

The following is a summary of "Lipid Metabolic Reprograming: the Unsung Hero in Breast Cancer Progression and Tumor ...

This study shows that engineered E. coli Nissle 1917 producing indole-3-acetic acid (IAA), an AhR agonist, modulate the tumor ...

A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through which ...